Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 0 | 0 | 0 | 32 |
| Cost of Goods | N/A | N/A | N/A | N/A | 8 |
| Gross Profit | N/A | N/A | N/A | N/A | 24 |
| Operating Expenses | 203 | 176 | 193 | -740 | 155 |
| Operating Income | -203 | -176 | -193 | 560 | -123 |
| Interest Expense | 93 | 85 | 0 | 0 | 16 |
| Other Income | 0 | 0 | -58 | 62 | 0 |
| Pre-tax Income | -296 | -260 | -251 | 623 | -139 |
| Net Income Continuous | -296 | -260 | -251 | 623 | -139 |
| Net Income | $-296 | $-260 | $-251 | $146 | $-139 |
| EPS Basic Total Ops | -23.60 | -20.80 | -20.00 | 15.02 | -10.40 |
| EPS Basic Continuous Ops | -23.68 | -20.83 | -20.09 | 45.77 | -10.23 |
| EPS Diluted Total Ops | -23.60 | -20.80 | -20.00 | 15.02 | -10.40 |
| EPS Diluted Continuous Ops | -23.68 | -20.83 | -20.09 | 45.77 | -10.23 |
| EBITDA(a) | $-120 | $-106 | $-135 | $740 | $-94 |